Trial
NCT01293123
Raltegravir Cerebrospinal Fluid Pharmacodynamic Study in HIV-Infected Individuals
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of California, San Diego
Collaborators
Merck Sharp & Dohme LLC
Condition
HIV
Intervention
Raltegravir
Why stopped
Did not meet enrollment goals
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-31